Health Universe Raises $6 Mn to Develop AI Agents for Medical Workflows

The new funds have brought the company’s valuation to $9.5 million

San Francisco-based Health Universe, an AI-based platform enterprise focused on automating complex healthcare workflows, has raised $6 million in seed funding led by Kleiner Perkins.

The fresh funds have brought the company’s valuation to $9.5 million. Health Universe develops an AI-enabled workflow orchestration platform for healthcare organizations, including academic medical centers and health systems. Its platform is designed to provide a secure and compliant environment where AI agents can be deployed to support clinical and operational processes.

The newly raised funds are intended to scale its platform, deepen integrations with oncology and clinical research teams, expand its engineering and data science teams, and strengthen integrations with clinical and research environments.

The company also aims to accelerate the deployment of AI agents across healthcare systems and life sciences organizations.

The company's HIPAA-compliant platform is designed to automate complex workflows across oncology, clinical research, and healthcare operations.

By incorporating inspectable, traceable, and auditable agents, Health Universe aims to reduce the time for manual administrative work burden.

The platform features several components designed to support AI-driven medical workflows.

These features include a secure workspace for deploying and managing AI agents using patient data from sources such as TEFCA, FHIR, or direct uploads. The platform also seeks to support population-level analysis by enabling users to build cohorts and run agents, while monitoring performance metrics such as cost, accuracy, and potential risks.

Additionally, the platform features tools such as Oncology Agent, designed to convert unstructured medical records into structured summaries covering diagnosis, staging, biomarkers, and treatment history, reducing manual review time.

Further, the Clinical Trials Agents support the creation of detailed trial protocols from brief study inputs and assist with regulatory submissions. The platform also incorporates governance, monitoring, and human oversight features to support use in regulated healthcare environments.

Furthermore, the early deployment reported that the platform has been used in clinical research settings to streamline processes such as trial setup timelines, indicating potential efficiency gains in workflow execution.

Stay tuned for more such updates on Digital Health News